The best indicator for Verisign (VRSN)
We backtested 366 indicators across daily, weekly and hourly charts on real Verisign (VRSN) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
KAMA 10/30 Cross
On the weekly chart, this is the strongest risk-adjusted edge we found for Verisign (VRSN) over ~28.5 years — beating buy-and-hold by 5.7% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Verisign (VRSN) — trailing buy-and-hold by 2.4% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | KAMA 10/30 Cross ✓ | Weekly | 20.9% | 0.74 | -60.3% | 65.0% | 20 | 5.7% |
| 2 | CCI (50) ✓ | Weekly | 19.1% | 0.7 | -60.6% | 70.0% | 30 | 4.0% |
| 3 | LSMA 30 Trend ✓ | Weekly | 17.2% | 0.69 | -51.4% | 50.0% | 104 | 2.0% |
| 4 | ROC (30) ✓ | Weekly | 19.6% | 0.69 | -63.7% | 50.0% | 46 | 4.4% |
| 5 | CMO (30) ✓ | Weekly | 19.6% | 0.69 | -63.7% | 50.0% | 46 | 4.4% |
| 6 | Momentum (30) ✓ | Weekly | 19.6% | 0.69 | -63.7% | 50.0% | 46 | 4.4% |
| 7 | Gann HiLo Activator ✓ | Weekly | 18.7% | 0.68 | -64.1% | 50.0% | 96 | 3.5% |
| 8 | Impulse MACD ✓ | Weekly | 15.2% | 0.68 | -42.3% | 47.0% | 83 | 0.0% |
| 9 | SMA 50/200 Cross ✓ | Daily | 19.8% | 0.67 | -65.8% | 70.6% | 17 | 4.5% |
| 10 | Linear Regression Slope ✓ | Weekly | 18.5% | 0.67 | -60.6% | 56.2% | 32 | 3.4% |
| 11 | UT Bot (ATR Trailing) ✓ | Weekly | 17.6% | 0.67 | -70.7% | 53.0% | 83 | 2.4% |
| 12 | Correlation Trend ✓ | Weekly | 18.5% | 0.67 | -60.6% | 56.2% | 32 | 3.4% |
| 13 | SMA 10/40 Cross ✓ | Weekly | 18.4% | 0.66 | -71.0% | 61.9% | 21 | 3.3% |
| 14 | Supertrend (10,3) ✓ | Weekly | 17.7% | 0.65 | -72.9% | 66.7% | 18 | 2.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Verisign (VRSN), KAMA 10/30 Cross on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.